Skip to content

KZIA

Kazia Therapeutics Ltd.

NASDAQ · Healthcare · Biotechnology · AU

$10.39
−4.33%
Ask drillr

Forward multiples

Based on analyst estimates

P/E forward
P/E 2026E
P/E 2027E
P/E 2028E
P/S forward

Trailing multiples

Trailing twelve months

P/E TTM
PEG TTM
Price / book
4.41x
Price / sales
Price / cash flow
-15.49x

Enterprise value

Enterprise value
$96.3M
EV / sales
6868.26x
EV / EBITDA
-7.46x
EV / EBIT
-7.46x
Market cap
$145.5M

Trailing, forward and enterprise-value multiples for the requested listing · Data as of Dec 1, 2025